{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:08:54Z","timestamp":1781136534378,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,8]]},"DOI":"10.7759\/cureus.31256","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T20:18:25Z","timestamp":1667938705000},"source":"Crossref","is-referenced-by-count":8,"title":["Importance of Low Pregnancy Associated Plasma Protein-A (PAPP-A) Levels During the First Trimester as a Predicting Factor for Adverse Pregnancy Outcomes: A Prospective Cohort Study of 2636 Pregnant Women"],"prefix":"10.7759","author":[{"given":"Maria","family":"Papamichail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zacharias","family":"Fasoulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Theodora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Rodolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Antsaklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4912","article-title":"Association of low maternal pregnancy-associated plasma protein A with adverse perinatal outcome","volume":"11","author":"Antsaklis P","year":"2019","unstructured":"Antsaklis P, Fasoulakis Z, Theodora M, Diakosavvas M, Kontomanolis EN. Association of low maternal pregnancy-associated plasma protein A with adverse perinatal outcome. Cureus. 2019, 11:e4912. 10.7759\/cureus.4912","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1933719113512532","article-title":"First-trimester levels of pregnancy-associated plasma protein A2 (PAPP-A2) in the maternal circulation are elevated in pregnancies that subsequently develop preeclampsia","volume":"21","author":"Crosley EJ","year":"2014","unstructured":"Crosley EJ, Durland U, Seethram K, MacRae S, Gruslin A, Christians JK. First-trimester levels of pregnancy-associated plasma protein A2 (PAPP-A2) in the maternal circulation are elevated in pregnancies that subsequently develop preeclampsia. Reprod Sci. 2014, 21:754-760. 10.1177\/1933719113512532","journal-title":"Reprod Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.102.007609","article-title":"Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation","volume":"68","author":"Monget P","year":"2003","unstructured":"Monget P, Mazerbourg S, Delpuech T, et al.. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol Reprod. 2003, 68:77-86. 10.1095\/biolreprod.102.007609","journal-title":"Biol Reprod"},{"key":"ref4","article-title":"Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspects","volume":"103","author":"Fialova L","year":"2002","unstructured":"Fialova L, Malbohan IM. Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspects. Bratisl Lek Listy. 2002, 103:194-205.","journal-title":"Bratisl Lek Listy"},{"key":"ref5","article-title":"Value of pregnancy-associated plasma protein-A for predicting adverse pregnancy outcome","volume":"1","author":"Mohamad Jafari R","year":"2019","unstructured":"Mohamad Jafari R, Masihi S, Barati M, Maraghi E, Sheibani S, Sheikhvatan M. Value of pregnancy-associated plasma protein-A for predicting adverse pregnancy outcome. Arch Iran Med. 2019, 1:584-587.","journal-title":"Arch Iran Med"},{"key":"ref6","article-title":"Low pregnancy-associated plasma protein A level in the first trimester","volume":"60","author":"Huynh L","year":"2014","unstructured":"Huynh L, Kingdom J, Akhtar S. Low pregnancy-associated plasma protein A level in the first trimester. Can Fam Phys. 2014, 60:899-903.","journal-title":"Can Fam Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4141","article-title":"Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications","volume":"33","author":"D'Antonio F","year":"2013","unstructured":"D'Antonio F, Rijo C, Thilaganathan B, Akolekar R, Khalil A, Papageourgiou A, Bhide A. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications. Prenat Diagn. 2013, 33:839-847. 10.1002\/pd.4141","journal-title":"Prenat Diagn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.06.052","article-title":"First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)","volume":"191","author":"Dugoff L","year":"2004","unstructured":"Dugoff L, Hobbins JC, Malone FD, et al.. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004, 191:1446-1451. 10.1016\/j.ajog.2004.06.052","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5001","article-title":"Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis","volume":"37","author":"Morris RK","year":"2017","unstructured":"Morris RK, Bilagi A, Devani P, Kilby MD. Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenat Diagn. 2017, 37:253-265. 10.1002\/pd.5001","journal-title":"Prenat Diagn"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/uog.8808","article-title":"Early fetal growth, PAPP-A and free \u03b2-hCG in relation to risk of delivering a small-for-gestational age infant","volume":"37","author":"Kirkegaard I","year":"2011","unstructured":"Kirkegaard I, Henriksen TB, Uldbjerg N. Early fetal growth, PAPP-A and free \u03b2-hCG in relation to risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol. 2011, 37:341-347. 10.1002\/uog.8808","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4174","article-title":"Pregnancy-associated plasma protein A levels and neonatal complications in post-date pregnancies","volume":"33","author":"Zizzo AR","year":"2013","unstructured":"Zizzo AR, Kirkegaard I, Henriksen TB, Ulbjerg N. Pregnancy-associated plasma protein A levels and neonatal complications in post-date pregnancies. Prenat Diagn. 2013, 33:965-972. 10.1002\/pd.4174","journal-title":"Prenat Diagn"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4946","article-title":"The risk of adverse pregnancy outcome among pregnancies with extremely low maternal PAPP-A","volume":"36","author":"Kaijomaa M","year":"2016","unstructured":"Kaijomaa M, Ulander VM, H\u00e4m\u00e4l\u00e4inen E, Alfthan H, Markkanen H, Heinonen S, Stefanovic V. The risk of adverse pregnancy outcome among pregnancies with extremely low maternal PAPP-A. Prenat Diagn. 2016, 36:1115-1120. 10.1002\/pd.4946","journal-title":"Prenat Diagn"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2017.03.099","article-title":"Maternal blood biomarkers of placentation to\u00a0predict low-birth-weight newborns: a meta-analysis","volume":"39","author":"Goto E","year":"2017","unstructured":"Goto E. Maternal blood biomarkers of placentation to\u00a0predict low-birth-weight newborns: a meta-analysis. J Obstet Gynaecol Can. 2017, 39:635-644. 10.1016\/j.jogc.2017.03.099","journal-title":"J Obstet Gynaecol Can"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.06.014","article-title":"Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women","volume":"203","author":"Audibert F","year":"2010","unstructured":"Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, Rey E. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol. 2010, 203:383.e1-383.e8. 10.1016\/j.ajog.2010.06.014","journal-title":"Am J Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/uog.6280","article-title":"First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia","volume":"33","author":"Poon LC","year":"2009","unstructured":"Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol. 2009, 33:23-33. 10.1002\/uog.6280","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5069","article-title":"Association of maternal serum PAPP-A levels, nuchal translucency and crown-rump length in first trimester with adverse pregnancy outcomes: retrospective cohort study","volume":"37","author":"Bilagi A","year":"2017","unstructured":"Bilagi A, Burke DL, Riley RD, Mills I, Kilby MD, Katie Morris R. Association of maternal serum PAPP-A levels, nuchal translucency and crown-rump length in first trimester with adverse pregnancy outcomes: retrospective cohort study. Prenat Diagn. 2017, 37:705-711. 10.1002\/pd.5069","journal-title":"Prenat Diagn"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.099","article-title":"Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers","volume":"199","author":"Dugoff L","year":"2008","unstructured":"Dugoff L, Cuckle HS, Hobbins JC, et al.. Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers. Am J Obstet Gynecol. 2008, 199:290.e1-290.e6. 10.1016\/j.ajog.2008.06.099","journal-title":"Am J Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2009.01001.x","article-title":"Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels","volume":"49","author":"Scott F","year":"2009","unstructured":"Scott F, Coates A, McLennan A. Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels. Aust NZ J Obstet Gynaecol. 2009, 49:258-262. 10.1111\/j.1479-828X.2009.01001.x","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.05.068","article-title":"Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes","volume":"191","author":"Krantz D","year":"2004","unstructured":"Krantz D, Goetzl L, Simpson JL, et al.. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004, 191:1452-1458. 10.1016\/j.ajog.2004.05.068","journal-title":"Am J Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118403-importance-of-low-pregnancy-associated-plasma-protein-a-papp-a-levels-during-the-first-trimester-as-a-predicting-factor-for-adverse-pregnancy-outcomes-a-prospective-cohort-study-of-2636-pregnant-women","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:55Z","timestamp":1707507715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118403-importance-of-low-pregnancy-associated-plasma-protein-a-papp-a-levels-during-the-first-trimester-as-a-predicting-factor-for-adverse-pregnancy-outcomes-a-prospective-cohort-study-of-2636-pregnant-women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.31256","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,8]]}}}